A four-month gatifloxacin-containing regimen for treating tuberculosis. [electronic resource]
Producer: 20141031Description: 1588-98 p. digitalISSN:- 1533-4406
- Adult
- Antitubercular Agents -- adverse effects
- Blood Glucose -- analysis
- Drug Administration Schedule
- Drug Therapy, Combination
- Ethambutol -- therapeutic use
- Female
- Fluoroquinolones -- adverse effects
- Gatifloxacin
- Humans
- Intention to Treat Analysis
- Isoniazid -- therapeutic use
- Male
- Mycobacterium tuberculosis -- isolation & purification
- Pyrazinamide -- therapeutic use
- Rifampin -- therapeutic use
- Tuberculosis, Pulmonary -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.